These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29767267)

  • 1. HDAC inhibitors, trichostatin A and valproic acid, increase E‑cadherin and vimentin expression but inhibit migration and invasion of cholangiocarcinoma cells.
    Wang JH; Lee EJ; Ji M; Park SM
    Oncol Rep; 2018 Jul; 40(1):346-354. PubMed ID: 29767267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells.
    Ji M; Lee EJ; Kim KB; Kim Y; Sung R; Lee SJ; Kim DS; Park SM
    Oncol Rep; 2015 May; 33(5):2299-308. PubMed ID: 25813246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells.
    Yang L; Chang Y; Cao P
    Exp Cell Res; 2018 Oct; 371(1):231-237. PubMed ID: 30107147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitor enhances the anti-tumor effect of gemcitabine: a special reference to gene-expression microarray analysis.
    Iwahashi S; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Mori H; Hanaoka J; Saito Y
    Oncol Rep; 2011 Nov; 26(5):1057-62. PubMed ID: 21805043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term stimulation with histone deacetylase inhibitor trichostatin a induces epithelial-mesenchymal transition in nasopharyngeal carcinoma cells without increasing cell invasion ability.
    Shen Z; Liao X; Shao Z; Feng M; Yuan J; Wang S; Gan S; Ha Y; He Z; Jie W
    BMC Cancer; 2019 Mar; 19(1):262. PubMed ID: 30902084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichostatin A, a histone deacetylase inhibitor, reverses epithelial-mesenchymal transition in colorectal cancer SW480 and prostate cancer PC3 cells.
    Wang X; Xu J; Wang H; Wu L; Yuan W; Du J; Cai S
    Biochem Biophys Res Commun; 2015 Jan; 456(1):320-6. PubMed ID: 25434997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichostatin A promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4/ERK1/2-dependent pathway.
    Liu D; Liu Y; Qi B; Gu C; Huo S; Zhao B
    Cancer Med; 2021 Aug; 10(15):5235-5245. PubMed ID: 34160902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Effects of Valproic Acid Treatment on Cell Survival and Epithelial-Mesenchymal Transition-Related Features of Human Gastric Cancer Cells.
    Jahani M; Khanahmad H; Nikpour P
    J Gastrointest Cancer; 2021 Jun; 52(2):676-681. PubMed ID: 32621111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition.
    Jin H; Zhao Y; Zhang S; Yang J; Zhang X; Ma S
    Mol Med Rep; 2018 May; 17(5):7274-7280. PubMed ID: 29568909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cells.
    Iwahashi S; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Mori H; Hanaoka J; Sugimoto K; Saito Y
    Int J Clin Oncol; 2011 Dec; 16(6):671-8. PubMed ID: 21556798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of histone deacetylase inhibitors on regenerative cell responses in human dental pulp cells.
    Luo Z; Wang Z; He X; Liu N; Liu B; Sun L; Wang J; Ma F; Duncan H; He W; Cooper P
    Int Endod J; 2018 Jul; 51(7):767-778. PubMed ID: 28375564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichostatin A Inhibits Epithelial Mesenchymal Transition Induced by TGF-β1 in Airway Epithelium.
    Park IH; Kang JH; Shin JM; Lee HM
    PLoS One; 2016; 11(8):e0162058. PubMed ID: 27571418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways.
    Jaidee R; Kukongviriyapan V; Senggunprai L; Prawan A; Jusakul A; Laphanuwat P; Kongpetch S
    Life Sci; 2022 May; 296():120427. PubMed ID: 35218764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors trichostatin A and vorinostat inhibit TGFβ2-induced lens epithelial-to-mesenchymal cell transition.
    Xie L; Santhoshkumar P; Reneker LW; Sharma KK
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4731-40. PubMed ID: 24994865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of obatoclax combined with gemcitabine on the biological activity of pancreatic cancer cells under hypoxic conditions.
    Hou XF; Li S; Wu C; Li K; Xu SN; Wang JF
    Mol Med Rep; 2018 Jul; 18(1):495-501. PubMed ID: 29749486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through Inhibition of the DNA Repair Protein Gamma-H2AX.
    Wang Y; Kuramitsu Y; Kitagawa T; Tokuda K; Baron B; Akada J; Nakamura K
    Target Oncol; 2015 Dec; 10(4):575-81. PubMed ID: 25940934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine.
    Donadelli M; Costanzo C; Beghelli S; Scupoli MT; Dandrea M; Bonora A; Piacentini P; Budillon A; Caraglia M; Scarpa A; Palmieri M
    Biochim Biophys Acta; 2007 Jul; 1773(7):1095-106. PubMed ID: 17555830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutlin-3 reverses the epithelial-mesenchymal transition in gemcitabine-resistant hepatocellular carcinoma cells.
    Wu Q; Wang X; Liu J; Zheng J; Liu Y; Li Y; Su F; Ou W; Wang R
    Oncol Rep; 2016 Sep; 36(3):1325-32. PubMed ID: 27430152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism].
    Rahimian A; Barati G; Mehrandish R; Mellati AA
    Mol Biol (Mosk); 2018; 52(3):474-481. PubMed ID: 29989579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells.
    Qiu YH; Wei YP; Shen NJ; Wang ZC; Kan T; Yu WL; Yi B; Zhang YJ
    Cell Physiol Biochem; 2013; 32(5):1331-41. PubMed ID: 24280681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.